![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Publisher's version)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Review |
|---|---|
| Title: | A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course |
| Creators Name: | Solomon, J.M., Paul, F., Chien, C., Oh, J. and Rotstein, D.L. |
| Abstract: | Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory disease of the central nervous system marked by relapses often associated with poor recovery and long-term disability. Magnetic resonance imaging (MRI) is recognized as an important tool for timely diagnosis of NMOSD as, in combination with serologic testing, it aids in distinguishing NMOSD from possible mimics. Although the role of MRI for disease monitoring after diagnosis is not as well established, MRI may provide important prognostic information and help differentiate between relapses and pseudorelapses. Increasing evidence of subclinical disease activity and the emergence of newly approved, highly effective immunotherapies for NMOSD adjure us to re-evaluate MRI as a tool to guide optimal treatment selection and escalation throughout the disease course. In this article we review the role of MRI in NMOSD diagnosis, prognostication, disease monitoring, and treatment selection. |
| Keywords: | Disease Activity, MRI, NMOSD, Prognosis |
| Source: | Therapeutic Advances in Neurological Disorders |
| ISSN: | 1756-2856 |
| Publisher: | Sage Publications |
| Volume: | 14 |
| Page Range: | 175628642110143 |
| Date: | 9 May 2021 |
| Official Publication: | https://doi.org/10.1177/17562864211014389 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
